JP2022126804A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022126804A5 JP2022126804A5 JP2022101163A JP2022101163A JP2022126804A5 JP 2022126804 A5 JP2022126804 A5 JP 2022126804A5 JP 2022101163 A JP2022101163 A JP 2022101163A JP 2022101163 A JP2022101163 A JP 2022101163A JP 2022126804 A5 JP2022126804 A5 JP 2022126804A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- retinal
- composition
- seq
- retinitis pigmentosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000002780 macular degeneration Diseases 0.000 claims 12
- 201000010099 disease Diseases 0.000 claims 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 11
- 208000017442 Retinal disease Diseases 0.000 claims 9
- 208000007014 Retinitis pigmentosa Diseases 0.000 claims 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims 8
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 6
- 208000035719 Maculopathy Diseases 0.000 claims 6
- 208000024080 Myopic macular degeneration Diseases 0.000 claims 6
- 206010038848 Retinal detachment Diseases 0.000 claims 6
- 206010064930 age-related macular degeneration Diseases 0.000 claims 6
- 230000004264 retinal detachment Effects 0.000 claims 6
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 206010012692 Diabetic uveitis Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 102000037865 fusion proteins Human genes 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 239000013598 vector Substances 0.000 claims 2
- 239000013604 expression vector Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024004787A JP2024026791A (ja) | 2016-09-02 | 2024-01-16 | 視覚機能再生剤又は視覚機能低下予防剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016172149 | 2016-09-02 | ||
| JP2016172149 | 2016-09-02 | ||
| JP2020050903A JP2020117513A (ja) | 2016-09-02 | 2020-03-23 | 視覚機能再生剤又は視覚機能低下予防剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020050903A Division JP2020117513A (ja) | 2016-09-02 | 2020-03-23 | 視覚機能再生剤又は視覚機能低下予防剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004787A Division JP2024026791A (ja) | 2016-09-02 | 2024-01-16 | 視覚機能再生剤又は視覚機能低下予防剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022126804A JP2022126804A (ja) | 2022-08-30 |
| JP2022126804A5 true JP2022126804A5 (enExample) | 2023-02-17 |
| JP7427208B2 JP7427208B2 (ja) | 2024-02-05 |
Family
ID=61301215
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018537436A Active JP6757024B2 (ja) | 2016-09-02 | 2017-09-01 | 視覚機能再生剤又は視覚機能低下予防剤 |
| JP2020050903A Withdrawn JP2020117513A (ja) | 2016-09-02 | 2020-03-23 | 視覚機能再生剤又は視覚機能低下予防剤 |
| JP2022101163A Active JP7427208B2 (ja) | 2016-09-02 | 2022-06-23 | 視覚機能再生剤又は視覚機能低下予防剤 |
| JP2024004787A Pending JP2024026791A (ja) | 2016-09-02 | 2024-01-16 | 視覚機能再生剤又は視覚機能低下予防剤 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018537436A Active JP6757024B2 (ja) | 2016-09-02 | 2017-09-01 | 視覚機能再生剤又は視覚機能低下予防剤 |
| JP2020050903A Withdrawn JP2020117513A (ja) | 2016-09-02 | 2020-03-23 | 視覚機能再生剤又は視覚機能低下予防剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024004787A Pending JP2024026791A (ja) | 2016-09-02 | 2024-01-16 | 視覚機能再生剤又は視覚機能低下予防剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11932679B2 (enExample) |
| EP (2) | EP4653537A2 (enExample) |
| JP (4) | JP6757024B2 (enExample) |
| CN (5) | CN109890404A (enExample) |
| CA (1) | CA3035651A1 (enExample) |
| WO (1) | WO2018043707A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11932679B2 (en) | 2016-09-02 | 2024-03-19 | Keio University | Agent for restoring visual function or agent for preventing deterioration in visual function |
| JP7299632B2 (ja) * | 2019-01-18 | 2023-06-28 | 株式会社レストアビジョン | 網膜疾患の予防および進行抑制、視覚認知行動機能の改善、および視覚機能強化 |
| CA3154358A1 (en) * | 2019-09-13 | 2021-03-18 | Restore Vision Inc. | Nucleic acid construct that encodes chimeric rhodopsin |
| US11771741B2 (en) | 2019-09-13 | 2023-10-03 | Restore Vision Inc. | Nucleic acid construct that encodes chimeric rhodopsin |
| JPWO2022059736A1 (enExample) * | 2020-09-17 | 2022-03-24 | ||
| CN118717946A (zh) * | 2023-03-29 | 2024-10-01 | 郑州大学第一附属医院 | 一种嵌合蛋白在治疗视神经变性疾病中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3521382B2 (ja) | 1997-02-27 | 2004-04-19 | 日本たばこ産業株式会社 | 細胞間接着及びシグナル伝達を媒介する細胞表面分子 |
| CA2685900A1 (en) * | 2006-05-04 | 2007-11-15 | Wayne State University | Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids |
| KR101197129B1 (ko) | 2009-09-14 | 2012-11-07 | 서강대학교산학협력단 | 글레오박터 로돕신 및 ａｔｐ 합성효소가 방향성을 갖도록 장착된 ａｔｐ 합성용 조성물 |
| CN106011073A (zh) | 2010-03-17 | 2016-10-12 | 小利兰·斯坦福大学托管委员会 | 光敏离子透过性分子 |
| KR101061482B1 (ko) | 2010-04-20 | 2011-09-02 | 서강대학교산학협력단 | 카로테노이드가 재구성된 글레오박터 로돕신 |
| EP3486253A1 (en) | 2010-11-05 | 2019-05-22 | The Board of Trustees of The Leland Stanford Junior University | Light-activated chimeric opsins and methods of using the same |
| EP2968476B1 (en) * | 2013-03-14 | 2021-05-05 | Wayne State University | A plasmin for use in enhancing delivery of therapeutic compounds to the eyes or for improving vision |
| CA3234028A1 (en) | 2014-03-11 | 2015-09-17 | Wayne State University | A modified mglur6 promoter and methods of use |
| US11932679B2 (en) | 2016-09-02 | 2024-03-19 | Keio University | Agent for restoring visual function or agent for preventing deterioration in visual function |
| JP7299632B2 (ja) | 2019-01-18 | 2023-06-28 | 株式会社レストアビジョン | 網膜疾患の予防および進行抑制、視覚認知行動機能の改善、および視覚機能強化 |
| CA3154358A1 (en) | 2019-09-13 | 2021-03-18 | Restore Vision Inc. | Nucleic acid construct that encodes chimeric rhodopsin |
| US11771741B2 (en) | 2019-09-13 | 2023-10-03 | Restore Vision Inc. | Nucleic acid construct that encodes chimeric rhodopsin |
-
2017
- 2017-09-01 US US16/329,631 patent/US11932679B2/en active Active
- 2017-09-01 CN CN201780066838.2A patent/CN109890404A/zh active Pending
- 2017-09-01 EP EP25201543.3A patent/EP4653537A2/en active Pending
- 2017-09-01 WO PCT/JP2017/031579 patent/WO2018043707A1/ja not_active Ceased
- 2017-09-01 EP EP17846710.6A patent/EP3508212B1/en active Active
- 2017-09-01 CN CN202311593358.5A patent/CN117701637A/zh active Pending
- 2017-09-01 CA CA3035651A patent/CA3035651A1/en active Pending
- 2017-09-01 JP JP2018537436A patent/JP6757024B2/ja active Active
- 2017-09-01 CN CN202311592670.2A patent/CN117701604A/zh active Pending
- 2017-09-01 CN CN202311592678.9A patent/CN117695375A/zh active Pending
- 2017-09-01 CN CN202311592868.0A patent/CN117701605A/zh active Pending
-
2020
- 2020-03-23 JP JP2020050903A patent/JP2020117513A/ja not_active Withdrawn
-
2022
- 2022-06-23 JP JP2022101163A patent/JP7427208B2/ja active Active
-
2024
- 2024-01-16 JP JP2024004787A patent/JP2024026791A/ja active Pending
- 2024-02-16 US US18/443,512 patent/US20240247049A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022126804A5 (enExample) | ||
| RU2468080C2 (ru) | Новый класс терапевтических белковых молекул | |
| Wiener et al. | The sequences of the reovirus serotype 1, 2, and 3 L1 genome segments and analysis of the mode of divergence of the reovirus serotypes | |
| EP4272728A3 (en) | Adeno-associated virus variant capsids and use for inhibiting angiogenesis | |
| US20200069794A1 (en) | Respiratory virus nucleic acid vaccines | |
| JP2008529536A5 (enExample) | ||
| JP2019089787A5 (enExample) | ||
| WO2019060454A3 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| JP2015501156A5 (enExample) | ||
| WO2017197355A3 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| JP2024178382A5 (enExample) | ||
| JPWO2020047124A5 (enExample) | ||
| JP2017506521A5 (enExample) | ||
| JP2018523668A5 (enExample) | ||
| JP2003503355A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| CN112552379B (zh) | 合成肽在制备防治新型冠状病毒感染药物中的用途 | |
| FI3561056T3 (fi) | Peptidi silmänpohjan ikärappeuman hoitamiseksi | |
| JPH09502348A (ja) | 遺伝学的に分岐したｈｉｖ−１株に対する中和抗体を誘導するペプチド | |
| Ishiguro et al. | Complete amino acid sequence of rat liver cytosolic alanine aminotransferase | |
| JP2009507474A5 (enExample) | ||
| JPH0920798A (ja) | ヒト抗ＨＢｓ抗体 | |
| JP5750216B2 (ja) | 新規リンカーを用いた抗菌剤および診断薬 | |
| JP2024543994A (ja) | 硝子体内投与用の機能性ａａｖカプシド | |
| TWI670064B (zh) | 抗病毒劑及治療病毒感染之方法 |